This Biotech Stock Soared: Why One Fund Sold $3 Million
A biotech rally can be thrilling, but a large fund selling into the run-up often signals caution. This article unpack...
A stock index tracks a group of stocks to represent market performance, guiding benchmarks and passive investment strategies.
28,657 articlesA biotech rally can be thrilling, but a large fund selling into the run-up often signals caution. This article unpack...
Alibaba is emerging as a potential sleeper AI winner in 2026, trading at a discount while advancing open-source AI an...
A tiny 0.06% fee on SCHD masks a much larger cost: a 38% decade-long performance gap versus peers, with outsized oppo...
A single high-yield ETF is emerging as a practical substitute for traditional bond portfolios, delivering monthly inc...
A fresh passively managed strategy centers on established dividend payers to deliver roughly $6,500 a year from a $10...
Global markets are buzzing as offshore crypto platforms increasingly offer pre-IPO exposure tied to SpaceX rumors. Tr...
A 68-year-old couple has relied on an 8% yield from a long-held closed-end fund for over a decade, sparking debate am...
May home sales fell again, highlighting an ongoing affordability squeeze as mortgage costs remain elevated. The data ...
Federal health officials warn of potential listeria in Wellsley Farms Atlantic salmon sold at BJ’s Wholesale Club. Th...
XRP tests the $1.40 support as bulls fight for momentum. Here are the three signals shaping its path this week.
JPMORGAN Global Research says the AI-related capital spend is not a fleeting hype cycle but a profitable buildout. Th...
As volatility rattles markets in early 2026, retirees are turning to a trio of low-volatility ETFs that blend income ...